Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChill Brands Regulatory News (CHLL)

Share Price Information for Chill Brands (CHLL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 2.10
Ask: 2.30
Change: 0.00 (0.00%)
Spread: 0.20 (9.524%)
Open: 2.20
High: 2.30
Low: 2.20
Prev. Close: 2.20
CHLL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Tobacco-Free Nicotine Product Line

23 Sep 2021 07:00

RNS Number : 6831M
Chill Brands Group PLC
23 September 2021
 

 

Chill Brands Group plc

('Chill', the 'Company' or the 'Group')

 

Launch of Tobacco-Free Nicotine Product Line

 

Chill Brands Group plc (LON:CHLL) (OTCQX:ZOEIF), the international CBD group, is pleased to announce the launch of an innovative new range of Tobacco-Free Nicotine ("TFN®") flavour pouches.

 

Highlights

 

● Chill joins short list of brands licensed to use TFN® from market leader, Next Generation Labs

 

● New product line exposes Chill to major growth opportunities in the worldwide flavour pouch market that is expected to reach US$32 billion by 2026

 

● The Company is among the first to use adult lifestyle marketing in the emerging tobacco-free nicotine product category through partnerships with renowned rodeo athletes

 

● Tobacco-free nicotine flavour pouches set to launch in retail outlets across the US and online via Chill.com in Q4 2021

 

The Group has developed a new line of tobacco-free nicotine flavour pouches that is set to launch in the coming months. These innovative new products have been created

using Next Generation Labs TFN® - a unique, market-leading nicotine product that is not derived from tobacco.

 

The Company's use of Next Generation Labs TFN® complements its existing lineup of CBD products which remain an anchor for its growth strategy. The global nicotine pouches market is projected to grow to US$32 billion by 2026. This launch is intended to pave the way for Chill to become a market leader through the sale of desirable CBD and TFN® nicotine alternatives.

 

Chill's new product line will be distributed through the Company's extensive network of retail partners and is positioned to benefit from shifting consumer sentiment. Recent months have seen some of the world's foremost tobacco companies set out plans for the gradual discontinuation of traditional tobacco products which may signal their ultimate social stigmatisation and decline. The Group is now well placed to capitalise on this underlying shift in consumer sentiment through its CBD and TFN® lines.

 

Highly significant marketing and promotional initiatives are now underway to support the expansion of the Chill tobacco-alternative product line. The Company is represented by a number of professional rodeo athletes who regularly appear in the media and are highly regarded by the rodeo community - a historical mainstay of the traditional chewing tobacco market. The Company is committed to underpinning its novel lifestyle marketing strategy by forming key partnerships in other sporting communities and looks forward to updating the market in due course. 

 

Chill Tobacco-Free Nicotine Flavour Pouches will be available online at Chill.com and at retail points of sale across the United States from Q4 2021.

 

Antonio Russo, Co-CEO of Chill Brands Group, said: "We are excited to be working with Next Generation Labs and are pleased to have secured use of its groundbreaking TFN® nicotine which will greatly improve our ability to compete with traditional tobacco and vape products while complementing our current tobacco alternative line of products. Our existing manufacturing, distribution, and sales capabilities have enabled Chill to make a rapid entrance to this market and we are confident that we will gain a running start in this multi-billion-dollar emerging product category."

 

About Chill Tobacco-Free Nicotine Flavour Pouches

 

Chill Tobacco-Free Nicotine Flavour Pouches are an alternative to the traditional smokeless tobacco products used by almost 5.9 million Americans and millions of others worldwide. Available in appetizing flavours including mint, mango, and lemon, the flavour pouches contain TFN® (tobacco-free nicotine) manufactured by Next Generation Labs. Users of the TFN® flavour pouches can expect familiar textures and the freedom to choose products that do not contain tobacco-derived nicotine. 

 

About TFN®

 

TFN® is a tobacco-free nicotine product exclusively manufactured by Next Generation Labs. TFN® nicotine is not derived from tobacco leaf, stem, reconstituted sheet, or expanded or post-production waste dust. The nicotine is made using a patented manufacturing process that begins with a natural starter material, and progressively builds around the molecules of that material to create a pure synthetic nicotine. TFN® is virtually tasteless and odourless, and is devoid of all tobacco-derived residual impurities.

 

More information about TFN® can be found at https://www.nextgenerationlabs.com.

 

-ENDS-

 

Media enquiries:

 

Chill Brands Group plc

 

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

 

Allenby Capital Limited (Financial Adviser and Broker)

 

+44 (0) 20 3328 5656

Nick Harriss / Nick Naylor (Corporate Finance)

 

 

Kelly Gardiner (Equity Sales)

 

 

 

Buchanan

 

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

 

Tel: +44 (0) 20 7466 5000

chillbrands@buchanan.uk.com

 

www.buchanan.uk.com

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASEDFUEEFSESU
Date   Source Headline
13th Sep 20224:36 pmRNSPrice Monitoring Extension
1st Sep 20223:45 pmRNSNotice of AGM
18th Aug 20227:00 amRNSAgreement for CBD Distribution Support
17th Aug 20224:41 pmRNSSecond Price Monitoring Extn
17th Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20227:00 amRNSUpdate on Synthetic Nicotine Products
29th Jul 20225:00 pmRNSTotal Voting Rights & Holdings in the Company
13th Jul 20224:40 pmRNSSecond Price Monitoring Extn
13th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20221:00 pmRNSIssue of Equity
30th Jun 20225:00 pmRNSTotal Voting Rights
23rd Jun 20227:00 amRNSAcquisition of Chill.com Domain Complete
21st Jun 20227:00 amRNSAdmission of New Shares & Total Voting Rights
17th Jun 20222:30 pmRNSResult of Open Offer
31st May 20225:00 pmRNSTotal Voting Rights
31st May 20227:00 amRNSOpen Offer to Shareholders
27th May 20225:30 pmRNSIssue of Equity
12th May 202210:17 amRNSResult of General Meeting
12th May 20229:30 amRNSBusiness Update
9th May 20227:00 amRNSProposed Open Offer
29th Apr 20225:30 pmRNSTotal Voting Rights
29th Apr 202211:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
26th Apr 20224:36 pmRNSCompany Raises £3.5m & Notice of GM
22nd Apr 202211:05 amRNSSecond Price Monitoring Extn
22nd Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSIssue of Shares to Marketing Partner
20th Apr 20227:30 amRNSIssue of Shares to Director
19th Apr 20224:35 pmRNSPrice Monitoring Extension
19th Apr 20227:00 amRNSAppointment of CEO & Board Changes
4th Apr 20222:05 pmRNSSecond Price Monitoring Extn
4th Apr 20222:00 pmRNSPrice Monitoring Extension
22nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20224:36 pmRNSPrice Monitoring Extension
15th Mar 20227:00 amRNSUpdate re Outstanding Promissory Note
14th Mar 202211:05 amRNSSecond Price Monitoring Extn
14th Mar 202211:00 amRNSPrice Monitoring Extension
9th Mar 202211:05 amRNSSecond Price Monitoring Extn
9th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:30 amRNSTrading Update
9th Feb 20228:00 amRNSChill Partners with Micro-Fulfilment Provider
7th Feb 20229:15 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSHolding(s) in Company
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20229:05 amRNSSecond Price Monitoring Extn
31st Jan 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.